approval · primary record
GARADACIMAB-GXII
FDA · BLA · 2025-06-16
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-06-16 |
| Brand | ANDEMBRY |
| Sponsor | CSL BEHRING LLC |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:37.938Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:GARADACIMAB-GXII:2025-06-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.